高级检索
当前位置: 首页 > 详情页

Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. [2]Department of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, China. [3]Candidate Branch of National Clinical Research Center for Skin Diseases, Beijing, China.
出处:
ISSN:

关键词: cardiovascular disease cohort study meta-analysis systematic review psoriasis

摘要:
Several studies have investigated the relationship between psoriasis and adverse cardiovascular outcomes. Previous meta-analyses have shown psoriasis to be a risk factor for adverse cardiovascular outcomes. However, the relationship has become uncertain with the emergence of many new studies.This study aimed to conduct an updated meta-analysis on cohort studies about the relationship between psoriasis and adverse cardiovascular outcomes.Electronic databases (accessed till January 2022) were searched systematically for cohort studies assessing the cardiovascular risk in psoriasis patients. This was a meta-analysis using a random-effect model; pooled analyses of several cardiovascular outcomes were also conducted.A total of 31 [hazard ratio (HR), 23; rate ratio (RR), 8] studies involving 665,009 patients with psoriasis and 17,902,757 non-psoriatic control subjects were included for the meta analysis. The pooled analyses according to each cardiovascular outcome revealed that pooled RR of patients for developing myocardial infarction, stroke, cardiovascular death, ischemic heart disease, thromboembolism and arrhythmia were 1.17 (95% confidence interval [CI], 1.11-1.24), 1.19 (95% CI, 1.11-1.27), 1.46 (95% CI, 1.26-1.69), 1.17 (95% CI, 1.02-1.34), 1.36 (95% CI, 1.20-1.55) and 1.35 (95% CI, 1.30-1.40), respectively. Meanwhile, the pooled RR of patients with mild and severe psoriasis for developing adverse cardiovascular outcomes were 1.18 (95% CI, 1.13-1.24) and 1.41 (95% CI, 1.31-1.52), respectively.The pooled analyses revealed that psoriasis is associated with all adverse cardiovascular outcomes of interest, especially in severe patients. Psoriasis remains an independent risk factor for adverse cardiovascular outcomes, which needs more attention from clinicians.Copyright © 2022 Liu, Cui, Liu, Huo, Zhang and Wang.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2022]版:
大类 | 3 区 医学
小类 | 3 区 心脏和心血管系统
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 心脏和心血管系统
JCR分区:
出版当年[2022]版:
Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2024]版:
Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子: 最新[2024版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
通讯作者:
通讯机构: [1]Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. [2]Department of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, China. [3]Candidate Branch of National Clinical Research Center for Skin Diseases, Beijing, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42326 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号